Drug recall
TIAZAC Capsules (diltiazem hydrochloride), 180mg, Extended Release, USP, 30 and 90 count bottles, Rx only, Mfg…
FDA recall event 30164 · Class III · Amerisource Health Services Corp
Key facts
| Event ID | 30164 |
|---|---|
| Recall numbers | D-050-5, D-051-5 |
| Recalling firm | Amerisource Health Services Corp |
| Product type | Drugs |
| Products | TIAZAC Capsules (diltiazem hydrochloride), 180mg, Extended Release, USP, 30 and 90 count bottles, Rx only, Mfg by: Biovail Corporation International, Mississauga, Ontario CANADA L5L 1J9, Mfg for…, TIAZAC Capsules (diltiazem hydrochloride) 300mg, Extended Release, USP, 30 and 90 count bottles, Rx only, Mfg by: Biovail Corporation International, Mississauga, Ontario CANADA L5L 1J9, Mfg for… |
| Classification | Class III |
| Status | Ongoing |
| Voluntary or mandated | Firm Initiated |
| Reason for recall | Dissolution failure (by manufacturer) |
| Initiation date | Oct 4, 2004 |
| City | Columbus |
| Country | United States |
| FEI number | 3000209995 |
At a glance
- 1–9 Products in this recall
- 10–99 FDA inspections of this firm (FEI)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug and product recalls
FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.
Source: U.S. Food and Drug Administration (FDA), Enforcement Reports